Ann: Response to Media Reports , page-4

Get real guys did anybody honestly believe, that after all
those years they would've ever got it of the ground. The low
share price has been reflective of a negative outcome anyway.
They do have the right to resubmit a revised proposal as far
as I can read the news. Hope they don't spend more money on
xolobene. Just maybe it leaves them with a stronger case, to
clear the hurdles at their tormin project.
I don't think that the placement at a large premium to the
market price was related to a positive outcome of xolobene.
Anyway I have written of my holding in MRC some time ago.
No point in selling it now